Ivana Magovcevic-Liebisch
CIK 1279281 · View on SEC EDGAR ↗
Insider
First SEC filing: July 21, 2021 · Latest: July 21, 2021
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 10 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 17, 2026 | ACRV | A | 20,275 | — | — | 20,275 Direct | — | Acquired | (price as of 2026-08-21) |
| May 18, 2026 | ACRV | A | 9,366 | — | — | 9,366 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 2, 2026 | QTRX | A | 23,372 | — | — | 43,607 Direct | +115.50% | Acquired | (price as of 2026-08-21) |
| June 13, 2025 | ACRV | A | 20,275 | — | — | 20,275 Direct | — | Acquired | (price as of 2026-08-21) |
| Feb. 8, 2024 | ACRV | A | 32,500 | — | — | 32,500 Direct | — | Acquired | (price as of 2026-08-21) |
| June 22, 2023 | SYRE | A | 1,950,000 | — | — | 1,950,000 Direct | — | Acquired | (price as of 2026-08-21) |
| June 7, 2022 | SYRE | A | 43,000 | — | — | 43,000 Direct | — | Acquired | (price as of 2026-08-21) |
| June 8, 2021 | SYRE | A | 40,000 | — | — | 40,000 Direct | — | Acquired | (price as of 2026-08-21) |
| June 8, 2020 | SYRE | A | 28,100 | — | — | 28,100 Direct | — | Acquired | (price as of 2026-08-21) |
| March 22, 2018 | SYRE | A | 36,800 | — | — | 36,800 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 17, 2026 | ACRV | Stock Option (Right to Buy) | Common Stock (20,275) | $1.52 | June 16, 2036 | 20,275 | Acquired |
| June 13, 2025 | ACRV | Stock Option (Right to Buy) | Common Stock (20,275) | $1.20 | June 12, 2035 | 20,275 | Acquired |
| Feb. 8, 2024 | ACRV | Stock Option (Right to Buy) | Common Stock (32,500) | $3.54 | Feb. 7, 2034 | 32,500 | Acquired |
| June 22, 2023 | SYRE | Stock Option (right to buy) | Common Stock (1,950,000) | $0.30 | June 22, 2033 | 1,950,000 | Acquired |
| June 7, 2022 | SYRE | Director Stock Option (right to buy) | Common Stock (43,000) | $0.73 | June 6, 2032 | 43,000 | Acquired |
| June 8, 2021 | SYRE | Director Stock Option (right to buy) | Common Stock (40,000) | $6.80 | June 7, 2031 | 40,000 | Acquired |
| June 8, 2020 | SYRE | Director Stock Option (right to buy) | Common Stock (28,100) | $8.89 | June 7, 2030 | 28,100 | Acquired |
| March 22, 2018 | SYRE | Director Stock Option (right to buy) | Common Stock (36,800) | $10.50 | March 21, 2028 | 36,800 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.